Government drug policy may fuel more illicit transaction

Market observers say that the inconsistent drug related policies of the government designed to unilaterally reduce the insurance drug prices for better finance stability in the national health insurance sector, has raised great concerns from the domestic pharmaceutical industry.

There is a consensus that the projected implementation of the incentive system on the purchase of low-priced drug...